On this page
Mylotarg
gemtuzumab ozogamicin
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Mylotarg
Proper name
gemtuzumab ozogamicin
Licence type
351(a)
BLA number
761060
Applicant
Wyeth Pharmaceuticals LLC
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 4.5MG | For Injection | Intravenous | Single-Dose Vial | Rx | September 1, 2017 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | September 1, 2024 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |